Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress
- PMID: 24396593
- PMCID: PMC3876768
- DOI: 10.1155/2013/617204
Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress
Abstract
Endocrine complications due to haemosiderosis are present in a significant number of patients with beta-thalassemia major (BTM) worldwide and often become barriers in their desire for parenthood. Thus, although spontaneous fertility can occur, the majority of females with BTM is infertile due to hypogonadotropic hypogonadism (HH) and need assisted reproductive techniques. Infertility in these women seems to be attributed to iron deposition and iron-induced oxidative stress (OS) in various endocrine organs, such as hypothalamus, pituitary, and female reproductive system, but also through the iron effect on other organs, such as liver and pancreas, contributing to the impaired metabolism of hormones and serum antioxidants. Nevertheless, the gonadal function of these patients is usually intact and fertility is usually retrievable. Meanwhile, a significant prooxidants/antioxidants imbalance with subsequent increased (OS) exists in patients with BTM, which is mainly caused by tissue injury due to overproduction of free radicals by secondary iron overload, but also due to alteration in serum trace elements and antioxidant enzymes. Not only using the appropriate antioxidants, essential trace elements, and minerals, but also regulating the advanced glycation end products, could probably reduce the extent of oxidative damage and related complications and retrieve BTM women's infertility.
Figures

Similar articles
-
Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in Beta thalassemia major patients: a review of the literature.Anemia. 2012;2012:270923. doi: 10.1155/2012/270923. Epub 2012 May 9. Anemia. 2012. PMID: 22645668 Free PMC article.
-
Thalassemia and infertility.Hum Fertil (Camb). 2016 Jun;19(2):90-6. doi: 10.1080/14647273.2016.1190869. Epub 2016 Jun 23. Hum Fertil (Camb). 2016. PMID: 27335221 Review.
-
Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications.Metabolites. 2024 Dec 20;14(12):717. doi: 10.3390/metabo14120717. Metabolites. 2024. PMID: 39728498 Free PMC article. Review.
-
Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications.Transfus Med. 2020 Oct;30(5):352-360. doi: 10.1111/tme.12707. Epub 2020 Aug 21. Transfus Med. 2020. PMID: 32820581 Clinical Trial.
-
A 10-year longitudinal study of evaluation of ovarian reserve in women with transfusion-dependent beta thalassaemia major.Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:38-43. doi: 10.1016/j.ejogrb.2019.04.046. Epub 2019 May 1. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31082742
Cited by
-
Thalassemia and assisted reproduction: non-transfusion-dependent thalassemia shows no significant effect on live birth rates after embryo transfer.Front Cell Dev Biol. 2025 Mar 21;13:1573572. doi: 10.3389/fcell.2025.1573572. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40191230 Free PMC article.
-
The selenium status in thalassemia patients in South East of iran.Int J Hematol Oncol Stem Cell Res. 2014 Oct 1;8(4):1-4. Int J Hematol Oncol Stem Cell Res. 2014. PMID: 25774261 Free PMC article.
-
Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells.Mol Med Rep. 2015 Jan;11(1):143-50. doi: 10.3892/mmr.2014.2769. Epub 2014 Oct 24. Mol Med Rep. 2015. PMID: 25351366 Free PMC article.
-
Oocyte quality in women with thalassaemia major: insights from IVF cycles.Eur J Obstet Gynecol Reprod Biol X. 2019 May 13;3:100048. doi: 10.1016/j.eurox.2019.100048. eCollection 2019 Jul. Eur J Obstet Gynecol Reprod Biol X. 2019. PMID: 31404374 Free PMC article.
-
Metabolic risk factors and fertility disorders: A narrative review of the female perspective.Reprod Biomed Soc Online. 2021 Oct 1;14:66-74. doi: 10.1016/j.rbms.2021.09.002. eCollection 2022 Mar. Reprod Biomed Soc Online. 2021. PMID: 34765754 Free PMC article. Review.
References
-
- Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Annals of the New York Academy of Sciences. 2010;1202:1–9. - PubMed
-
- Waseem F, Khemomal KA, Sajid R. Antioxidant status in beta thalassemia major: a single-center study. Indian Journal of Pathology and Microbiology. 2011;54(4):761–763. - PubMed
-
- Skordis N, Petrikkos L, Toumba M, et al. Update on fertility in thalassaemia major. Pediatric Endocrinology Reviews. 2004;2(supplement 2):296–302. - PubMed
-
- Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with thalassaemia major. Pediatric Endocrinology Reviews. 2007;5(2):642–648. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources